Showing results (21-30 of 97) with videos related to
Sort By:
Pageof 10
Current Cancer Drug Targets|July 27, 2012
Perspectives on mTOR inhibitors for castration-refractory prostate cancerSalvatore L Burgio, Francesco Fabbri, Ian J Seymour, et al.Tumori|June 29, 2002
Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: a phase I studyGiovanni Luca Frassineti, Toni Ibrahim, Wainer Zoli, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I studyToni Ibrahim, Wainer Zoli, Giovanni Luca Frassineti, et al.Anti-Cancer Drugs|September 16, 2009
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell linesIvan Vannini, Wainer Zoli, Francesco Fabbri, et al.International Journal of Molecular Sciences|July 16, 2014
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancerSamanta Salvi, Daniele Calistri, Giorgia Gurioli, et al.International Journal of Oncology|August 31, 2016
[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell linesToni Ibrahim, Chiara Liverani, Laura Mercatali, et al.The International Journal of Biological Markers|January 19, 2010
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patientsValentina Casadio, Sara Bravaccini, Roberta Gunelli, et al.Journal of Cellular Physiology|October 14, 2005
p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patientsPaola Ulivi, Wainer Zoli, Daniele Calistri, et al.The Prostate|October 1, 2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expressionFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.Biomed Research International|March 20, 2013
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot studyValentina Casadio, Daniele Calistri, Samanta Salvi, et al.Pageof 10